Endogenous Estradiol in Elderly Individuals

Authors:
  • SVS. Vannasaeng
    S. Vannasaeng
  • NPN. Poungvarin
    N. Poungvarin
  • SPS. Ploybutr
    S. Ploybutr
  • SUS. Udompunthurak
    S. Udompunthurak
  • PJP. Jamjumras
    P. Jamjumras
  • LFL. Fairbanks
    L. Fairbanks

Abstract
ESTROGEN replacement therapy (ERT) has been reported to be associated with a decreased risk for dementia and better cognitive function in postmenopausal women. In the Baltimore Longitudinal Study of Aging,1 a sample of 472 postmenopausal or perimenopausal women was followed for 16 years. After adjustment for educational level, investigators found a relative risk of Alzheimer disease (AD) in estrogen users of 0.46 compared with nonusers. Paganini-Hill and Henderson2 found that the risk for AD decreased with longer duration of estrogen use. Results of observational studies demonstrate that postmenopausal women perform better on name recall3 and immediate and delayed paragraph recall4 but not on clock drawing5 after ERT. Results of randomized controlled trials indicate that estrogen therapy improved cognitive function in nondemented postmenopausal women6-9 but that it is not helpful in women with AD.10-12